About Dellwin Pharmaceuticals
Dellwin Pharmaceuticals is a Healthcare company. Manufacturing and supplying pharmaceutical formulations globally, with a focus on quality and innovation. Its Indian entity Dell Win Pharmaceuticals Private Limited reported revenue of ₹4.68 Cr. Dellwin Pharmaceuticals offers products and services including Tablets and Capsules and Injections. Its focus areas include Research and Development, Innovation, Drug Delivery Systems and Pharmaceuticals.
Company details
Dellwin Pharmaceuticals is acknowledged worldwide for providing a broad range of pharmaceutical formulations that address medical needs. Headquartered in Mumbai, India, it holds certifications such as WHO GMP, cGMP, and ISO 9001:2000, and operates in over 30 countries. Continuous research and development activities are conducted to innovate medicines, while quality control measures ensure products meet global standards. Strategic partnerships and manufacturing collaborations are utilized to penetrate new markets and enhance global presence by 2025, emphasizing cost-effective and safe solutions for patients.
- SectorsHealthcare
- Email••••••••
- Website dellwinpharma.com
- Legal Name Dell Win Pharmaceuticals Pvt Ltd
- Date of Incorporation 17 Sep, 2019
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹4.68 Cr
FY 2024 · -6% YoY
- Indian entity net profit₹14 Lakh
FY 2024 · 3% margin
- Indian entity EBITDA₹38.7 Lakh
FY 2024 · 8% margin
Associated legal entities of Dellwin Pharmaceuticals
Dellwin Pharmaceuticals operates through Dell Win Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dell Win Pharmaceuticals Private Limited CIN U24100TG2019PTC135474 | Active | 17 Sep 2019 | Hyderabad, Telangana | ₹4.7 Cr | 2 | View details |
Products & Services of Dellwin Pharmaceuticals
Dellwin Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injections.
Tablets and capsules are manufactured and supplied in various formulations to meet medical needs across different therapeutic segments.
Injections, including liquid and dry forms, are produced and distributed for use in global markets to address a range of health conditions.
Board of directors of Dell Win Pharmaceuticals Private Limited (Dellwin Pharmaceuticals)
Dell Win Pharmaceuticals Private Limited is the primary company behind Dellwin Pharmaceuticals. The board of Dell Win Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sujatha Beeravalli, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sujatha Beeravalli DIN 08522577 | Director | 17 Sep 2019 | 7 yrs 1 mo | Dell Win Pharmaceuticals Private Limited |
| Rami Reddy Marri DIN 08522578 | Director | 17 Sep 2019 | 7 yrs 1 mo | Dell Win Pharmaceuticals Private Limited |
Financials of Dellwin Pharmaceuticals
Figures of Dell Win Pharmaceuticals Private Limited, the primary company behind Dellwin Pharmaceuticals, for FY 2024. Revenue was ₹4.68 Cr (-6% year on year). Net profit was ₹14 Lakh (3% margin). EBITDA was ₹38.7 Lakh (8% margin). Revenue has grown at a compounded annual rate of +172% over three years.
- ₹4.68 CrRevenue · FY 2024 · -6% YoY
- ₹14 LakhNet profit · 3% margin
- ₹38.7 LakhEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- +172%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Dell Win Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Dellwin Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dellwin Pharmaceuticals
The primary company behind Dellwin Pharmaceuticals, Dell Win Pharmaceuticals Private Limited, reported revenue of ₹4.68 Cr for FY 2024, down 6% year on year.
Dellwin Pharmaceuticals is acknowledged worldwide for providing a broad range of pharmaceutical formulations that address medical needs. Headquartered in Mumbai, India, it holds certifications such as WHO GMP, cGMP, and ISO 9001:2000, and operates in over 30 countries. Continuous research and development activities are conducted to innovate medicines, while quality control measures ensure products meet global standards. Strategic partnerships and manufacturing collaborations are utilized to penetrate new markets and enhance global presence by 2025, emphasizing cost-effective and safe solutions for patients.
Dellwin Pharmaceuticals offers Tablets and Capsules and Injections.
Dellwin Pharmaceuticals operates through Dell Win Pharmaceuticals Private Limited.
The legal entities of Dellwin Pharmaceuticals currently have 2 directors, including Sujatha Beeravalli, Rami Reddy Marri.